Back to Search Start Over

Clinical, biochemical and genetic profiles of patients with mucopolysaccharidosis type IVA (Morquio A syndrome) in Malaysia: the first national natural history cohort study.

Authors :
Leong, Huey Yin
Abdul Azize, Nor Azimah
Chew, Hui Bein
Keng, Wee Teik
Thong, Meow Keong
Mohd Khalid, Mohd Khairul Nizam
Hung, Liang Choo
Mohamed Zainudin, Norzila
Ramlee, Azura
Md Haniffa, Muzhirah Aisha
Yakob, Yusnita
Ngu, Lock Hock
Source :
Orphanet Journal of Rare Diseases; 6/14/2019, Vol. 14 Issue 1, pN.PAG-N.PAG, 1p
Publication Year :
2019

Abstract

<bold>Background: </bold>Mucopolysaccharidosis IVA (MPS IVA) is an autosomal recessive lysosomal storage disease due to N-acetylgalactosamine-6-sulfatase (GALNS) deficiency. It results in accumulation of the glycosaminoglycans, keratan sulfate and chondroitin-6-sulfate, leading to skeletal and other systemic impairments. Data on MPS IVA in Asian populations are scarce.<bold>Methods: </bold>This is a multicentre descriptive case series of 21 patients comprising all MPS IVA patients in Malaysia. Mutational analysis was performed by PCR and Sanger sequencing of the GALNS gene in 17 patients.<bold>Results: </bold>The patients (15 females and 6 males) had a mean age (± SD) of 15.5 (± 8.1) years. Mean age at symptom onset was 2.6 (± 2.1) years and at confirmed diagnosis was 6.9 (± 4.5) years. The study cohort included patients from all the main ethnic groups in Malaysia - 57% Malay, 29% Chinese and 14% Indian. Common presenting symptoms included pectus carinatum (57%) and genu valgum (43%). Eight patients (38%) had undergone surgery, most commonly knee surgeries (29%) and cervical spine decompression (24%). Patients had limited endurance with lower mean walking distances with increasing age. GALNS gene analysis identified 18 distinct mutations comprising 13 missense, three nonsense, one small deletion and one splice site mutation. Of these, eight were novel mutations (Tyr133Ser, Glu158Valfs*12, Gly168*, Gly168Val, Trp184*, Leu271Pro, Glu320Lys, Leu508Pro). Mutations in exons 1, 5 and 9 accounted for 51% of the mutant alleles identified.<bold>Conclusions: </bold>All the MPS IVA patients in this study had clinical impairments. A better understanding of the natural history and the clinical and genetic spectrum of MPS IVA in this population may assist early diagnosis, improve management and permit timely genetic counselling and prenatal diagnosis. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
17501172
Volume :
14
Issue :
1
Database :
Complementary Index
Journal :
Orphanet Journal of Rare Diseases
Publication Type :
Academic Journal
Accession number :
136999623
Full Text :
https://doi.org/10.1186/s13023-019-1105-6